en
svPress releases
Regulatory press release 2026-08-19
Xspray Pharma receives Complete Response Letter (CRL) from FDA for Dasynoc
Regulatory press release 2026-08-05
Xspray Pharma Interim Report Second Quarter 2026
Regulatory press release 2026-06-04
Xspray Pharma Receives CRL from U.S. FDA for Nilopki™
Regulatory press release 2026-05-12
Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026
Regulatory press release 2026-04-30
New number of shares and votes in Xspray Pharma after new share issue April 2026
-
Latest report
Interim Report Q2 2026 -
Subscribe
Get our latest press releases and reports